Form4insider filings, from the source

SEC Form 4 · accession 0001127602-19-009259

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lonnel Coats
Officer — President and CEO · Director
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2019M10,835—A68,914D
Common StockF1Feb 28, 2019M8,390—A77,304D
Common StockF1Feb 28, 2019M5,363—A82,667D
Common StockF1Feb 28, 2019M23,513—A106,180D
Common StockFeb 28, 2019F18,641$5.51D87,539D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Feb 28, 2019M10,835D——Common Stock10,8350D
Restricted Stock UnitsF1,F4—Feb 28, 2019M8,390D——Common Stock8,3908,390D
Restricted Stock UnitsF1,F5—Feb 28, 2019M5,363D——Common Stock5,36310,725D
Restricted Stock UnitsF1,F6—Feb 28, 2019M23,513D——Common Stock23,51347,027D

Explanation of responses